Vcanbio Cell & Gene Engineering Corp Ltd (600645) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.028x

Based on the latest financial reports, Vcanbio Cell & Gene Engineering Corp Ltd (600645) has a cash flow conversion efficiency ratio of 0.028x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥103.70 Million ≈ $15.17 Million USD) by net assets (CN¥3.76 Billion ≈ $550.45 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Vcanbio Cell & Gene Engineering Corp Ltd worth for the company's overall valuation and market capitalisation.

Vcanbio Cell & Gene Engineering Corp Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Vcanbio Cell & Gene Engineering Corp Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Vcanbio Cell & Gene Engineering Corp Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vcanbio Cell & Gene Engineering Corp Ltd ranked by their cash flow conversion efficiency. Explore 600645 operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Nordic American Tankers Limited F:B3O	0.144x
Pabrik Kertas Tjiwi Kimia Tbk JK:TKIM	-0.011x
Alphamin Res V:AFM	0.124x
Shenzhen Lihexing Co. Ltd. SHE:301013	-0.037x
E-Mart KO:139480	0.069x
Wacker Neuson SE F:WAC	0.041x
Frontier Group Holdings Inc NASDAQ:ULCC	1.110x
Zhuzhou Huarui Precision Cutting Tools Co Ltd SHG:688059	0.039x

Annual Cash Flow Conversion Efficiency for Vcanbio Cell & Gene Engineering Corp Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Vcanbio Cell & Gene Engineering Corp Ltd from 1998 to 2025. View today's stock price for Vcanbio Cell & Gene Engineering Corp Ltd for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥3.75 Billion ≈ $549.45 Million	CN¥313.63 Million ≈ $45.89 Million	0.084x	+7.17%
2024-12-31	CN¥3.66 Billion ≈ $535.44 Million	CN¥285.19 Million ≈ $41.73 Million	0.078x	-0.99%
2023-12-31	CN¥3.80 Billion ≈ $555.86 Million	CN¥299.02 Million ≈ $43.76 Million	0.079x	+9.82%
2022-12-31	CN¥3.65 Billion ≈ $534.64 Million	CN¥261.89 Million ≈ $38.32 Million	0.072x	-21.10%
2021-12-31	CN¥3.53 Billion ≈ $516.95 Million	CN¥320.96 Million ≈ $46.97 Million	0.091x	+30.22%
2020-12-31	CN¥3.50 Billion ≈ $512.51 Million	CN¥244.35 Million ≈ $35.76 Million	0.070x	-0.02%
2019-12-31	CN¥3.46 Billion ≈ $506.41 Million	CN¥241.49 Million ≈ $35.34 Million	0.070x	+60.09%
2018-12-31	CN¥2.98 Billion ≈ $436.71 Million	CN¥130.08 Million ≈ $19.04 Million	0.044x	+1.38%
2017-12-31	CN¥1.63 Billion ≈ $239.17 Million	CN¥70.27 Million ≈ $10.28 Million	0.043x	-47.58%
2016-12-31	CN¥1.75 Billion ≈ $256.34 Million	CN¥143.67 Million ≈ $21.02 Million	0.082x	+1587.16%
2015-12-31	CN¥1.68 Billion ≈ $246.10 Million	CN¥8.17 Million ≈ $1.20 Million	0.005x	-97.46%
2014-12-31	CN¥1.16 Billion ≈ $169.20 Million	CN¥221.45 Million ≈ $32.41 Million	0.192x	+14.17%
2013-12-31	CN¥660.07 Million ≈ $96.59 Million	CN¥110.72 Million ≈ $16.20 Million	0.168x	-32.93%
2012-12-31	CN¥281.54 Million ≈ $41.20 Million	CN¥70.41 Million ≈ $10.30 Million	0.250x	-39.12%
2011-12-31	CN¥268.85 Million ≈ $39.34 Million	CN¥110.44 Million ≈ $16.16 Million	0.411x	-42.99%
2010-12-31	CN¥244.13 Million ≈ $35.72 Million	CN¥175.93 Million ≈ $25.74 Million	0.721x	+38.01%
2009-12-31	CN¥239.23 Million ≈ $35.01 Million	CN¥124.92 Million ≈ $18.28 Million	0.522x	+10.06%
2008-12-31	CN¥256.31 Million ≈ $37.51 Million	CN¥121.60 Million ≈ $17.79 Million	0.474x	-21.23%
2007-12-31	CN¥185.42 Million ≈ $27.13 Million	CN¥111.68 Million ≈ $16.34 Million	0.602x	+45.63%
2006-12-31	CN¥184.04 Million ≈ $26.93 Million	CN¥76.12 Million ≈ $11.14 Million	0.414x	-19.44%
2005-12-31	CN¥164.95 Million ≈ $24.14 Million	CN¥84.69 Million ≈ $12.39 Million	0.513x	+175.49%
2004-12-31	CN¥309.95 Million ≈ $45.36 Million	CN¥57.76 Million ≈ $8.45 Million	0.186x	+62.98%
2003-12-31	CN¥365.02 Million ≈ $53.41 Million	CN¥41.74 Million ≈ $6.11 Million	0.114x	+377.40%
2002-12-31	CN¥357.83 Million ≈ $52.36 Million	CN¥-14.75 Million ≈ $-2.16 Million	-0.041x	+75.21%
2001-12-31	CN¥414.06 Million ≈ $60.59 Million	CN¥-68.84 Million ≈ $-10.07 Million	-0.166x	-327.53%
2000-12-31	CN¥433.95 Million ≈ $63.50 Million	CN¥31.71 Million ≈ $4.64 Million	0.073x	+632.86%
1999-12-31	CN¥414.12 Million ≈ $60.60 Million	CN¥4.13 Million ≈ $604.18K	0.010x	+112.92%
1998-12-31	CN¥416.47 Million ≈ $60.94 Million	CN¥-32.14 Million ≈ $-4.70 Million	-0.077x	--

About Vcanbio Cell & Gene Engineering Corp Ltd

SHG:600645 China Biotechnology

Market Cap

$1.32 Billion

CN¥9.03 Billion CNY

Market Cap Rank

#7807 Global

#1770 in China

Share Price

CN¥19.29

Change (1 day)

+1.26%

52-Week Range

CN¥16.74 - CN¥32.94

All Time High

CN¥68.93